SCHEMBL7435560

SCHEMBL7435560

Nc1c(O)ncc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.47
GPR3 P46089 1/20 0.47
PDPK1 O15530 1/20 0.42
PLAU P00749 2/20 0.41
F12 P00748 1/20 0.41
NCF1 P14598 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
BACE1 P56817 1/20 0.41
ALDH1A1 P00352 5/20 0.40
HPGD P15428 4/20 0.40
HSD17B10 Q99714 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
GLA P06280 3/20 0.40
CASP1 P29466 2/20 0.40
CASP7 P55210 2/20 0.40
MAOA P21397 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
CHRM2 P08172 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28301397 0.78 KDM4E (0.50) KDM4EGPR3PDPK1PLAUF12
SCHEMBL9125784 0.78 KDM4E (0.50) KDM4EGPR3ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL30790223 0.78 KDM4E (0.50) KDM4EGPR3ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL2747465 0.77 KDM4E (0.48) KDM4EGPR3PDPK1ALDH1A1HSD17B10
SCHEMBL17942817 0.77 KDM4E (0.48) KDM4EGPR3PDPK1PLAUF12
SCHEMBL2747868 0.75 KDM4E (0.47) KDM4EGPR3ALDH1A1HPGDHSD17B10
SCHEMBL3293976 0.75 KDM4E (0.47) KDM4EGPR3PDPK1PLAUF12
SCHEMBL38666100 0.75 KDM4E (0.47) KDM4EGPR3PDPK1PLAUF12
SCHEMBL7315366 0.75 POLB (0.50) KDM4EGPR3PDPK1PLAUALDH1A1
SCHEMBL3298150 0.75 KDM4E (0.47) KDM4EGPR3PDPK1PLAUF12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed